These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 30652182)
1. A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model. Banerjee I; De M; Dey G; Bharti R; Chattopadhyay S; Ali N; Chakrabarti P; Reis RL; Kundu SC; Mandal M Biomater Sci; 2019 Feb; 7(3):1161-1178. PubMed ID: 30652182 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy. Banerjee I; De K; Mukherjee D; Dey G; Chattopadhyay S; Mukherjee M; Mandal M; Bandyopadhyay AK; Gupta A; Ganguly S; Misra M Acta Biomater; 2016 Jul; 38():69-81. PubMed ID: 27109765 [TBL] [Abstract][Full Text] [Related]
3. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. Hervieu A; Rébé C; Végran F; Chalmin F; Bruchard M; Vabres P; Apetoh L; Ghiringhelli F; Mignot G J Invest Dermatol; 2013 Feb; 133(2):499-508. PubMed ID: 22951720 [TBL] [Abstract][Full Text] [Related]
4. Topical CpG enhances the response of murine malignant melanoma to dacarbazine. Najar HM; Dutz JP J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132 [TBL] [Abstract][Full Text] [Related]
5. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner. Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma. Tsubaki M; Takeda T; Obata N; Kawashima K; Tabata M; Imano M; Satou T; Nishida S J Cell Physiol; 2019 Aug; 234(10):17975-17989. PubMed ID: 30834527 [TBL] [Abstract][Full Text] [Related]
7. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression. Faião-Flores F; Quincoces Suarez JA; Fruet AC; Maria-Engler SS; Pardi PC; Maria DA PLoS One; 2015; 10(3):e0118702. PubMed ID: 25742310 [TBL] [Abstract][Full Text] [Related]
9. Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxel. Eshita Y; Ji RC; Onishi M; Kobayashi T; Mizuno M; Yoshida J; Kubota N; Onishi Y Drug Deliv Transl Res; 2015 Feb; 5(1):38-50. PubMed ID: 25787338 [TBL] [Abstract][Full Text] [Related]
10. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity. Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975 [TBL] [Abstract][Full Text] [Related]
14. Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma. Trafalis DT; Camoutsis C; Papageorgiou A Melanoma Res; 2005 Aug; 15(4):273-81. PubMed ID: 16034305 [TBL] [Abstract][Full Text] [Related]
15. Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy. Zhao P; Qiu L; Zhou S; Li L; Qian Z; Zhang H Int J Nanomedicine; 2021; 16():2107-2121. PubMed ID: 33737808 [TBL] [Abstract][Full Text] [Related]
16. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment. Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988 [TBL] [Abstract][Full Text] [Related]
17. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma. Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205 [TBL] [Abstract][Full Text] [Related]
18. Dacarbazine nanoparticle topical delivery system for the treatment of melanoma. Hafeez A; Kazmi I Sci Rep; 2017 Nov; 7(1):16517. PubMed ID: 29184162 [TBL] [Abstract][Full Text] [Related]
19. [Dacarbazine]. D'incan M; Souteyrand P Ann Dermatol Venereol; 2001 Apr; 128(4):517-25. PubMed ID: 11395650 [No Abstract] [Full Text] [Related]